Company Filing History:
Years Active: 2006-2009
Title: Gillian Bates: Innovator in Neurodegenerative Disease Detection
Introduction
Gillian Bates is a prominent inventor based in London, GB. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented inventions. With a total of 2 patents, her work focuses on methods for detecting amyloid-like fibrils and protein aggregates, which are indicative of diseases such as Alzheimer's and Huntington's disease.
Latest Patents
Gillian Bates' latest patents include a method for detecting amyloid-like fibrils or protein aggregates. This invention relates to methods that identify the presence of detergent- or urea-insoluble amyloid-like fibrils or protein aggregates on filters. These fibrils or aggregates are crucial for diagnosing neurodegenerative diseases. Additionally, her second patent involves a composition and method for detecting diseases associated with amyloid-like fibril or protein aggregate formation. This invention provides novel compositions for understanding the onset or progress of diseases like Huntington's disease and includes methods for monitoring fibril formation and identifying inhibitors.
Career Highlights
Throughout her career, Gillian Bates has worked with esteemed organizations, including the Max Planck Society for the Advancement of Science. Her research has significantly advanced the understanding of neurodegenerative diseases and has the potential to lead to new diagnostic and therapeutic approaches.
Collaborations
Gillian has collaborated with notable scientists such as Erich Wanker and Hans Lehrach. These collaborations have enriched her research and contributed to the development of her patented inventions.
Conclusion
Gillian Bates is a trailblazer in the field of neurodegenerative disease research. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving diagnostic methods for critical diseases.